This company has been marked as potentially delisted and may not be actively trading. Celyad (CYAD) News Today Add Compare Share Share Headlines Stock AnalysisBuy This Stock CYAD Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Celyad Oncology annonce la cessation des activités R&DAugust 26, 2025 | fr.finance.yahoo.comCelyad Oncology Announces Discontinuation of R&D ActivitiesAugust 26, 2025 | finance.yahoo.comCelyad Oncology Announces €1 Million Private PlacementJuly 28, 2025 | finance.yahoo.comLa biotech Celyad évalue plusieurs pistes pour survivreJune 24, 2025 | msn.comCelyad Oncology annonce une revue de sa stratégie d’entrepriseJune 24, 2025 | fr.finance.yahoo.comCelyad Oncology Announces Strategic ReviewJune 24, 2025 | finance.yahoo.comCelyad Oncology SA GAAP EPS of -€0.14, revenue of €0.2MApril 2, 2025 | seekingalpha.comCelyad Oncology to Present at the 2024 SITC Annual MeetingOctober 7, 2024 | finance.yahoo.comCelyad Oncology Announces Appointment of Matt Kane as Chief Executive OfficerSeptember 16, 2024 | finance.yahoo.comCelyad Oncology Reports First Half Year 2024 Financial Results and Recent Business HighlightsSeptember 13, 2024 | finance.yahoo.comCelyad Oncology SA (CYADB.XC)July 19, 2024 | finance.yahoo.comCelyad Oncology Reports Full Year 2023 Financial Results and Recent Business HighlightsApril 4, 2024 | finance.yahoo.comCSBR Champions Oncology, Inc.March 29, 2024 | seekingalpha.comCelyad Oncology SA: Celyad Oncology provides fourth quarter 2023 business update and 2024 outlookJanuary 17, 2024 | finanznachrichten.deCelyad Oncology provides fourth quarter 2023 business update and 2024 outlookJanuary 16, 2024 | finance.yahoo.comCelyad Oncology: Information on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 May 2007)December 17, 2023 | businesswire.comCelyad Announces Management ChangeDecember 4, 2023 | finance.yahoo.comInformation on the Total Number of Voting Rights and Shares (Article 15 of the Law of 2 MayNovember 14, 2023 | tmcnet.comCelyad Oncology Share Price (CYAD.BR)November 11, 2023 | lse.co.ukCelyad Oncology SA: Celyad Oncology reports third quarter 2023 financial results and recent business highlightsNovember 9, 2023 | finanznachrichten.deCelyad Oncology reports third quarter 2023 financial results and recent business highlightsNovember 9, 2023 | finance.yahoo.comCelyad Oncology SA: Celyad Oncology announces the termination of its American Depository Receipt programSeptember 26, 2023 | finanznachrichten.deCelyad Oncology to Terminate ADR ProgramSeptember 25, 2023 | marketwatch.comCelyad Oncology announces the termination of its American Depository Receipt programSeptember 25, 2023 | finance.yahoo.comCelyad Oncology SA: Publication of a Rectified Transparency Notification Received From Fortress Investment Group LLCSeptember 15, 2023 | finance.yahoo.comCelyad Oncology SA: Publication of a Transparency Notification Received from Tolefi SASeptember 12, 2023 | businesswire.comCelyad Oncology SA (CYAD.BR)September 12, 2023 | ca.finance.yahoo.comCelyad Oncology SA: Publication of a Transparency Notification Received From Fortress Investment Group LLCSeptember 7, 2023 | finance.yahoo.comCelyad Oncology SA: Celyad Oncology Reports First Half 2023 Financial Results and Recent Business HighlightsSeptember 4, 2023 | finanznachrichten.deCelyad Oncology Reports First Half 2023 Financial Results and Recent Business HighlightsSeptember 4, 2023 | finance.yahoo.comCelyad Oncology (CYADY) Earnings Dates & ReportsSeptember 4, 2023 | investing.comCelyad Oncology Receives Approximately EUR 9.8m in Private Placement Commitments From Historical ShareholdersAugust 29, 2023 | finance.yahoo.comCelyad Oncology SA: Celyad Oncology receives approximately EUR 9.8m in private placement commitments from historical shareholdersAugust 25, 2023 | finanznachrichten.deCelyad Oncology SA (CYADY)July 19, 2023 | investing.comCelyad Oncology SA: Celyad Oncology announces receipt of Nasdaq delisting noticeMay 16, 2023 | finanznachrichten.deCelyad Oncology Announces Receipt of Nasdaq Delisting NoticeMay 15, 2023 | finance.yahoo.comCelyad plans to delist from Nasdaq amid cash woesMay 5, 2023 | msn.comCelyad Oncology reports first quarter 2023 financial results and recent business highlightsMay 5, 2023 | finance.yahoo.comCelyad Oncology Announces Intent to Voluntarily Delist American Depository Shares From NasdaqMay 5, 2023 | finance.yahoo.comCelyad Oncology SA: Celyad Oncology Announces Receipt of Nasdaq Initial Notification on ADS Bid PriceApril 27, 2023 | finanznachrichten.deCelyad Oncology Announces Receipt of Nasdaq Initial Notification on ADS Bid PriceApril 24, 2023 | finance.yahoo.comCelyad Oncology announces receipt of Nasdaq noticeApril 4, 2023 | finance.yahoo.comCelyad Oncology SA (NASDAQ:CYAD) Q4 2022 Earnings Call TranscriptMarch 27, 2023 | finance.yahoo.comCelyad Oncology Appoints Georges Rawadi As CEO - Quick FactsMarch 24, 2023 | markets.businessinsider.comCelyad Oncology Appoints Georges Rawadi as Its New CEOMarch 24, 2023 | finance.yahoo.comCelyad Oncology SA: Celyad Oncology Reports Full Year 2022 Financial Results and Recent Business HighlightsMarch 23, 2023 | finanznachrichten.deCelyad Oncology reports full year 2022 financial results and recent business highlightsMarch 23, 2023 | finance.yahoo.comCelyad Oncology to Announce Full Year 2022 Financial Results and Host Conference CallMarch 17, 2023 | finance.yahoo.comCelyad slumps ~30% as board to put proposal to continue activities on vote at shareholders' meetMarch 15, 2023 | msn.comCelyad Oncology announces non-cash impairmentMarch 15, 2023 | finance.yahoo.com Get Celyad News Delivered to You Automatically Sign up to receive the latest news and ratings for CYAD and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CYAD Media Mentions By Week CYAD Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYAD News Sentiment▼0.001.05▲Average Medical News Sentiment CYAD News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYAD Articles This Week▼20▲CYAD Articles Average Week Get the Latest News and Ratings for CYAD and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Celyad and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Adverum Biotechnologies News Cue Biopharma News Aligos Therapeutics News Werewolf Therapeutics News InflaRx News KALA BIO News PDS Biotechnology News Immix Biopharma News Adlai Nortye News Precision BioSciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYAD) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe man running the U.S. dollar… is hoarding goldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Celyad SA Please log in to your account or sign up in order to add this asset to your watchlist. Share Celyad With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
